US20020150921A1
(en)
*
|
1996-02-09 |
2002-10-17 |
Francis Barany |
Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
|
SK288019B6
(sk)
|
1999-12-24 |
2012-11-05 |
Aventis Pharma Limited |
Azaindoles derivatives, their use and pharmaceutical composition containing thereof
|
YU54202A
(sh)
*
|
2000-01-18 |
2006-01-16 |
Agouron Pharmaceuticals Inc. |
Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
|
US20050009876A1
(en)
*
|
2000-07-31 |
2005-01-13 |
Bhagwat Shripad S. |
Indazole compounds, compositions thereof and methods of treatment therewith
|
US6897231B2
(en)
*
|
2000-07-31 |
2005-05-24 |
Signal Pharmaceuticals, Inc. |
Indazole derivatives as JNK inhibitors and compositions and methods related thereto
|
US7211594B2
(en)
|
2000-07-31 |
2007-05-01 |
Signal Pharmaceuticals, Llc |
Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith
|
WO2002016348A1
(fr)
*
|
2000-08-09 |
2002-02-28 |
Astrazeneca Ab |
Derives bicycliques antiangiogeniques
|
EP1317442B1
(fr)
|
2000-09-11 |
2005-11-16 |
Chiron Corporation |
Derives de quinolinone comme inhibiteurs de tyrosine kinase
|
DE10046029A1
(de)
*
|
2000-09-18 |
2002-03-28 |
Bayer Ag |
Indazole
|
JP4535680B2
(ja)
*
|
2001-04-16 |
2010-09-01 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
新規1h−インダゾール化合物
|
GB0115109D0
(en)
|
2001-06-21 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
US7642278B2
(en)
|
2001-07-03 |
2010-01-05 |
Novartis Vaccines And Diagnostics, Inc. |
Indazole benzimidazole compounds
|
US7064215B2
(en)
|
2001-07-03 |
2006-06-20 |
Chiron Corporation |
Indazole benzimidazole compounds
|
FR2827861B1
(fr)
*
|
2001-07-27 |
2004-04-02 |
Aventis Pharma Sa |
Derives des indazoles ou des indoles, leur utilisation en medecine humaine et plus particulierement en cancerologie
|
US20040077702A1
(en)
*
|
2001-09-14 |
2004-04-22 |
Wen-Mei Fu |
Treatment of nuerodegenerative diseases
|
JP4542338B2
(ja)
*
|
2001-09-26 |
2010-09-15 |
ファイザー イタリア ソシエタ ア レスポンサビリタ リミタータ |
キナーゼ阻害因子として活性なアミノインダゾール誘導体、それらの製造方法及びそれらを含有する医薬組成物
|
US7271261B2
(en)
*
|
2001-10-19 |
2007-09-18 |
Ortho-Mcneil Pharmaceutical, Inc. |
Substituted benzimidazoles and imidazo-[4,5]-pyridines
|
US6897208B2
(en)
|
2001-10-26 |
2005-05-24 |
Aventis Pharmaceuticals Inc. |
Benzimidazoles
|
FR2831537B1
(fr)
*
|
2001-10-26 |
2008-02-29 |
Aventis Pharma Sa |
Nouveaux derives de benzimidazoles, leur procede de preparation, leur application a titre de medicament, compositions pharmaceutiques et nouvelle utilisation
|
FR2831536A1
(fr)
*
|
2001-10-26 |
2003-05-02 |
Aventis Pharma Sa |
Nouveaux derives de benzimidazoles, leur procede de preparation, leur application a titre de medicament, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de kdr
|
IL161576A0
(en)
*
|
2001-10-26 |
2004-09-27 |
Aventis Pharma Inc |
Benzimidazoles and analogues and their use as protein kinases inhibitors
|
US7074805B2
(en)
*
|
2002-02-20 |
2006-07-11 |
Abbott Laboratories |
Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
|
US6867320B2
(en)
*
|
2002-02-21 |
2005-03-15 |
Asahi Kasei Pharma Corporation |
Substituted phenylalkanoic acid derivatives and use thereof
|
US7351729B2
(en)
*
|
2002-03-08 |
2008-04-01 |
Signal Pharmaceuticals, Llc |
JNK inhibitors for use in combination therapy for treating or managing proliferative disorders and cancers
|
FR2836914B1
(fr)
|
2002-03-11 |
2008-03-14 |
Aventis Pharma Sa |
Indazoles substitues, compositions les contenant, procede de fabrication et utilisation
|
US7166293B2
(en)
*
|
2002-03-29 |
2007-01-23 |
Carlsbad Technology, Inc. |
Angiogenesis inhibitors
|
US20050119278A1
(en)
*
|
2002-05-16 |
2005-06-02 |
Che-Ming Teng |
Anti-angiogenesis methods
|
CN1668733A
(zh)
*
|
2002-05-30 |
2005-09-14 |
细胞基因公司 |
利用jnk或mkk抑制剂调节细胞分化并治疗骨髓增生异常和脊髓发育不良综合症的方法
|
WO2003101968A1
(fr)
*
|
2002-05-31 |
2003-12-11 |
Eisai Co., Ltd. |
Compose de pyrazole et composition medicinale le contenant
|
JP2004075673A
(ja)
*
|
2002-06-19 |
2004-03-11 |
Mitsubishi Chemicals Corp |
化合物およびこれを用いた有機電界発光素子
|
GB0218625D0
(en)
*
|
2002-08-10 |
2002-09-18 |
Astex Technology Ltd |
Pharmaceutical compounds
|
US7186716B2
(en)
|
2002-08-12 |
2007-03-06 |
Sugen, Inc. |
3-Pyrrol-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors
|
US20040087642A1
(en)
*
|
2002-10-24 |
2004-05-06 |
Zeldis Jerome B. |
Methods of using and compositions comprising a JNK inhibitor for the treatment, prevention, management and/or modification of pain
|
EP1582211A1
(fr)
*
|
2002-12-03 |
2005-10-05 |
Kyowa Hakko Kogyo Co., Ltd. |
Inhibiteur de jnk
|
JP3814285B2
(ja)
|
2002-12-19 |
2006-08-23 |
ファイザー・インク |
眼疾患の治療に有用なプロテインキナーゼ阻害剤としての2−(1h−インダゾール−6−イルアミノ)−ベンズアミド化合物
|
US20050019366A1
(en)
*
|
2002-12-31 |
2005-01-27 |
Zeldis Jerome B. |
Drug-coated stents and methods of use therefor
|
US6933311B2
(en)
*
|
2003-02-11 |
2005-08-23 |
Abbott Laboratories |
Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
|
WO2004074283A1
(fr)
*
|
2003-02-21 |
2004-09-02 |
Pfizer Inc. |
Derives d'amino-thiazole substitues par n-heterocyclyle en tant qu'inhibiteurs de la proteine kinase
|
ES2214150B1
(es)
*
|
2003-02-27 |
2005-12-01 |
J. URIACH & CIA S.A. |
"nuevos derivados de pirazolopiridinas".
|
UA81453C2
(en)
*
|
2003-02-27 |
2008-01-10 |
|
Pyrazolopyridine derivates
|
ATE363905T1
(de)
|
2003-04-17 |
2007-06-15 |
Janssen Pharmaceutica Nv |
2-phenyl-benzimidazol und 2-phenyl-imidazo-4,5)- pyridin-derivate als checkpoint-kinase-cds1 (chk2)-hemmer zur behandlung von krebs
|
FR2854159B1
(fr)
*
|
2003-04-25 |
2008-01-11 |
Aventis Pharma Sa |
Nouveaux derives de l'indole, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de kdr
|
US7015233B2
(en)
*
|
2003-06-12 |
2006-03-21 |
Abbott Laboratories |
Fused compounds that inhibit vanilloid subtype 1 (VR1) receptor
|
TWI372050B
(en)
|
2003-07-03 |
2012-09-11 |
Astex Therapeutics Ltd |
(morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
|
ITRM20030355A1
(it)
*
|
2003-07-18 |
2005-01-19 |
Sigma Tau Ind Farmaceuti |
Composti ad attivita' citotossica derivati della combretastatina.
|
PL2256106T3
(pl)
|
2003-07-22 |
2015-08-31 |
Astex Therapeutics Ltd |
Związki 3,4-pochodne 1h-pirazolu i ich zastosowanie jako kinazy zależne od cyklin (cdk) i modulatory kinazy syntazy glikogenu-3 (gsk-3)
|
ATE553092T1
(de)
*
|
2003-07-30 |
2012-04-15 |
Kyowa Hakko Kirin Co Ltd |
Indazolderivate
|
AU2004260759B2
(en)
*
|
2003-07-30 |
2010-04-22 |
Kyowa Hakko Kirin Co., Ltd. |
Protein kinase inhibitors
|
US7008953B2
(en)
*
|
2003-07-30 |
2006-03-07 |
Agouron Pharmaceuticals, Inc. |
3, 5 Disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
|
US20050090529A1
(en)
*
|
2003-07-31 |
2005-04-28 |
Pfizer Inc |
3,5 Disubstituted indazole compounds with nitrogen-bearing 5-membered heterocycles, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
|
KR20060054410A
(ko)
*
|
2003-08-01 |
2006-05-22 |
제네랩스 테크놀로지스, 인코포레이티드 |
플라비비리다에에 대한 2고리 이미다졸 유도체
|
US20050113576A1
(en)
*
|
2003-08-05 |
2005-05-26 |
Chih-Hung Lee |
Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
|
WO2005014554A1
(fr)
*
|
2003-08-08 |
2005-02-17 |
Astex Therapeutics Limited |
Composes 1h-indazole-3-carboxamide utilises comme modulateurs de la mapkap kinase
|
CA2535665A1
(fr)
|
2003-08-14 |
2005-02-24 |
Asahi Kasei Pharma Corporation |
Derive d'acide arylalcanoique substitue et son utilisation
|
JP2005089457A
(ja)
|
2003-09-03 |
2005-04-07 |
Yung Shin Pharmaceutical Industry Co Ltd |
骨成長を促進するまたは骨吸収を阻害するための薬剤組成物
|
US6984652B2
(en)
*
|
2003-09-05 |
2006-01-10 |
Warner-Lambert Company Llc |
Gyrase inhibitors
|
TWI352705B
(en)
*
|
2003-09-08 |
2011-11-21 |
Aventis Pharma Inc |
Thienopyrazoles
|
KR101163800B1
(ko)
*
|
2003-10-15 |
2012-07-09 |
산텐 세이야꾸 가부시키가이샤 |
신규 인다졸 유도체
|
JP2007510671A
(ja)
*
|
2003-11-06 |
2007-04-26 |
セルジーン・コーポレーション |
アスベスト関連疾患および障害の治療および管理のための、jnk阻害剤の使用方法およびそれを含む組成物
|
CA2543820C
(fr)
|
2003-11-07 |
2012-07-10 |
Chiron Corporation |
Methodes de synthese de composes de quinolinone
|
WO2005055700A2
(fr)
*
|
2003-11-17 |
2005-06-23 |
Aerogrow International, Inc. |
Dispositifs et procedes pour la culture de plantes
|
EP2065383A1
(fr)
|
2003-11-19 |
2009-06-03 |
Signal Pharmaceuticals, Inc. |
Composés d'indazoles et procédés d'utilisation associés en tant qu'inhibiteurs de kinase de protéine
|
US7488817B2
(en)
*
|
2004-02-02 |
2009-02-10 |
The Trustees Of The University Of Pennsylvania |
Metal complex protein kinase inhibitors
|
BRPI0509580A
(pt)
*
|
2004-03-30 |
2007-11-27 |
Pfizer Prod Inc |
combinações de inibidores de transdução de sinal
|
WO2005094823A1
(fr)
*
|
2004-03-30 |
2005-10-13 |
Kyowa Hakko Kogyo Co., Ltd. |
INHIBITEUR DE Flt-3
|
GB0409080D0
(en)
*
|
2004-04-23 |
2004-05-26 |
Biofocus Discovery Ltd |
Compounds which interact with protein kinases
|
WO2006010595A1
(fr)
*
|
2004-07-27 |
2006-02-02 |
Novartis Ag |
Inhibiteurs de hsp90
|
US20070054916A1
(en)
*
|
2004-10-01 |
2007-03-08 |
Amgen Inc. |
Aryl nitrogen-containing bicyclic compounds and methods of use
|
FR2876584B1
(fr)
*
|
2004-10-15 |
2007-04-13 |
Centre Nat Rech Scient Cnrse |
Utilisation de la kenpaullone pour la fabrication de medicaments pour le traitement de la mucoviscidose et de maladies liees a un defaut d'adressage des proteines dans les cellules
|
WO2006054143A1
(fr)
*
|
2004-11-17 |
2006-05-26 |
Pfizer Inc. |
Formes polymorphes de {5-[3-(4,6-difluoro-1h-benzimidazol-2-yl)-1h-indazol-5-yl]-4-methyl-pyridin-3-ylmethyl}-ethyl-amine
|
US20060116519A1
(en)
*
|
2004-11-17 |
2006-06-01 |
Agouron Pharmaceuticals, Inc. |
Synthesis of 5-bromo-4-methyl-pyridin-3-ylmethyl)-ethyl-carbamic acid tert-butyl ester
|
BRPI0518255A2
(pt)
*
|
2004-11-23 |
2008-11-11 |
Celgene Corp |
mÉtodos de tratamento ou prevenÇço de uma lesço do sistema nervoso central, para reduzir ou evitar um efeito adverso, e composiÇço farmacÊutica
|
JP5507049B2
(ja)
|
2004-12-30 |
2014-05-28 |
アステックス、セラピューティックス、リミテッド |
医薬品
|
CA2594474C
(fr)
|
2005-01-21 |
2016-03-29 |
Astex Therapeutics Limited |
Composes pharmaceutiques
|
US20090036435A1
(en)
|
2005-01-21 |
2009-02-05 |
Astex Therapeutics Limited |
Pharmaceutical Compounds
|
JPWO2006080450A1
(ja)
|
2005-01-27 |
2008-06-19 |
協和醗酵工業株式会社 |
Igf−1r阻害剤
|
GT200600042A
(es)
*
|
2005-02-10 |
2006-09-27 |
Aventis Pharma Inc |
Compuestos de bis arilo y heteroarilo sustituido como antagonistas selectivos de 5ht2a
|
US20070004777A1
(en)
*
|
2005-03-23 |
2007-01-04 |
Bhagwat Shripad S |
Methods for treating or preventing acute myelogenous leukemia
|
SI1869020T1
(sl)
|
2005-03-29 |
2011-02-28 |
Icos Corp |
Derivati heteroaril uree, ki so uporabni za inhibicijo chk1
|
EP1891051A2
(fr)
*
|
2005-04-29 |
2008-02-27 |
Celgene Corporation |
Feste formen von 1-(5-(ih-i,2,4-riazol-5-yl-)(1h-indazol-3-yl-))-3-(2-piperidylethoxy-)benzen
|
CN101223157B
(zh)
|
2005-05-17 |
2013-03-06 |
诺瓦提斯公司 |
合成杂环化合物的方法
|
US7541367B2
(en)
|
2005-05-31 |
2009-06-02 |
Janssen Pharmaceutica, N.V. |
3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders
|
US7470787B2
(en)
|
2005-07-11 |
2008-12-30 |
Aerie Pharmaceuticals, Inc. |
Isoquinoline compounds
|
WO2007058626A1
(fr)
*
|
2005-11-16 |
2007-05-24 |
S*Bio Pte Ltd |
Composes d'indazole
|
PL1957074T3
(pl)
|
2005-11-29 |
2014-08-29 |
Novartis Ag |
Preparaty chinolinonów
|
JP2009523845A
(ja)
*
|
2006-01-23 |
2009-06-25 |
クリスタルゲノミクス インコーポレーテッド |
たんぱく質キナーゼの活性を阻害するイミダゾピリジン誘導体、これの製造方法およびこれを含む薬学組成物
|
WO2007091107A1
(fr)
*
|
2006-02-10 |
2007-08-16 |
Summit Corporation Plc |
Traitement de la dystrophie musculaire de duchenne
|
EP2001882A1
(fr)
*
|
2006-03-23 |
2008-12-17 |
F. Hoffmann-La Roche AG |
Dérivés d'indazole substitués, leur fabrication et leur utilisation comme agents pharmaceutiques
|
WO2008001886A1
(fr)
|
2006-06-30 |
2008-01-03 |
Kyowa Hakko Kirin Co., Ltd. |
Inhibiteur d'aurora
|
CN101484427A
(zh)
|
2006-06-30 |
2009-07-15 |
协和发酵麒麟株式会社 |
Abl激酶抑制剂
|
JPWO2008020606A1
(ja)
*
|
2006-08-16 |
2010-01-07 |
協和発酵キリン株式会社 |
血管新生阻害剤
|
EP2054390B1
(fr)
*
|
2006-08-25 |
2012-04-11 |
Abbott Laboratories |
Dérivés d'indazole inhibant trpv1, et leur utilisation
|
CL2007002617A1
(es)
|
2006-09-11 |
2008-05-16 |
Sanofi Aventis |
Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto.
|
EP2526948A1
(fr)
|
2006-09-20 |
2012-11-28 |
Aerie Pharmaceuticals, Inc. |
Inhibiteurs de la RHO-kinase
|
US8916552B2
(en)
|
2006-10-12 |
2014-12-23 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
EP2073807A1
(fr)
|
2006-10-12 |
2009-07-01 |
Astex Therapeutics Limited |
Combinaisons pharmaceutiques
|
US20100022517A1
(en)
*
|
2006-12-18 |
2010-01-28 |
Richards Lori A |
Ophthalmic formulation of rho kinase inhibitor compound
|
US8071779B2
(en)
|
2006-12-18 |
2011-12-06 |
Inspire Pharmaceuticals, Inc. |
Cytoskeletal active rho kinase inhibitor compounds, composition and use
|
JP2010513557A
(ja)
|
2006-12-20 |
2010-04-30 |
アボット・ラボラトリーズ |
疼痛治療のためのtrpv1バニロイド受容体アンタゴニストとしてのn−(5,6,7,8−テトラヒドロナフタレン−1−イル)尿素誘導体および関連化合物
|
US8455513B2
(en)
|
2007-01-10 |
2013-06-04 |
Aerie Pharmaceuticals, Inc. |
6-aminoisoquinoline compounds
|
US8063089B2
(en)
*
|
2007-02-28 |
2011-11-22 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Inhibitors of nucleophosmin (NPM) and methods for inducing apoptosis
|
JPWO2008111441A1
(ja)
|
2007-03-05 |
2010-06-24 |
協和発酵キリン株式会社 |
医薬組成物
|
US8648069B2
(en)
|
2007-06-08 |
2014-02-11 |
Abbvie Inc. |
5-substituted indazoles as kinase inhibitors
|
MX2009013213A
(es)
*
|
2007-06-08 |
2010-03-30 |
Abbott Lab |
Indazoles 5-sustituidos 5-heteroarilo como inhibidores de cinasa.
|
EP2214675B1
(fr)
*
|
2007-10-25 |
2013-11-20 |
Genentech, Inc. |
Procédé de préparation de composés de thiénopyrimidine
|
US8455514B2
(en)
|
2008-01-17 |
2013-06-04 |
Aerie Pharmaceuticals, Inc. |
6-and 7-amino isoquinoline compounds and methods for making and using the same
|
EP2489660A1
(fr)
*
|
2008-03-20 |
2012-08-22 |
Abbott Laboratories |
Procédés de fabrication d'agents de système nerveux central qui sont des antagonistes TRPV1
|
KR101269393B1
(ko)
|
2008-04-28 |
2013-05-29 |
아사히 가세이 파마 가부시키가이샤 |
페닐프로피온산 유도체 및 이의 용도
|
US8106039B2
(en)
*
|
2008-04-30 |
2012-01-31 |
The Trustees Of The University Of Pennsylvania |
Metal complex phosphatidyl-inositol-3-kinase inhibitors
|
US8450344B2
(en)
|
2008-07-25 |
2013-05-28 |
Aerie Pharmaceuticals, Inc. |
Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
|
CA2756568C
(fr)
|
2009-04-06 |
2018-02-13 |
University Health Network |
Inhibiteurs de kinases et procede de traitement du cancer avec ceux-ci
|
EP3053913B1
(fr)
|
2009-05-01 |
2018-03-07 |
Aerie Pharmaceuticals, Inc. |
Inhibiteurs à double mécanisme pour le traitement d'une maladie
|
HUE028259T2
(en)
*
|
2009-08-10 |
2016-12-28 |
Samumed Llc |
Inhibitors of Wnt signaling signal indazole and their therapeutic use
|
EP2464231A4
(fr)
*
|
2009-08-10 |
2013-02-06 |
Samumed Llc |
Indazoles utiles comme inhibiteurs de la voie de signalisation de wnt/bêta-caténine et utilisations thérapeutiques de ceux-ci
|
AR078887A1
(es)
|
2009-11-06 |
2011-12-07 |
Boehringer Ingelheim Int |
Derivados arilo y heteroarilcarbonilo de hexahidroindenopiridina y octahidrobenzoquinolina y composiciones farmaceuticas que los contienen.
|
JP5822844B2
(ja)
|
2009-12-21 |
2015-11-24 |
サミュメッド リミテッド ライアビリティ カンパニー |
1H−ピラゾロ[3,4−b]ピリジンおよびその治療的使用
|
JP5442906B2
(ja)
|
2010-04-06 |
2014-03-19 |
ユニバーシティ・ヘルス・ネットワーク |
キナーゼインヒビターおよびこれを用いた癌の治療方法
|
WO2012020725A1
(fr)
*
|
2010-08-10 |
2012-02-16 |
塩野義製薬株式会社 |
Dérivé hétérocyclique présentant un antagonisme pour le récepteur npy y5
|
RU2016124136A
(ru)
|
2010-08-18 |
2018-12-03 |
СЭМЬЮМЕД, ЭлЭлСи |
Дикетоны и гидроксикетоны в качестве активатора сигнального пути катенина
|
TWI537258B
(zh)
|
2010-11-05 |
2016-06-11 |
百靈佳殷格翰國際股份有限公司 |
六氫茚并吡啶及八氫苯并喹啉之芳基-及雜環芳基羰基衍生物
|
AU2011338389A1
(en)
|
2010-12-09 |
2013-06-13 |
Amgen Inc. |
Bicyclic compounds as Pim inhibitors
|
CA2830780A1
(fr)
|
2011-03-22 |
2012-09-27 |
Amgen Inc. |
Composes d'azole utilises en tant qu'inhibiteurs des pim
|
EP2694060A4
(fr)
*
|
2011-04-01 |
2014-09-10 |
Univ Utah Res Found |
Analogues de 3-(1h-benzo[d]imidazol-2-yl)-1h-indazole substitués en tant qu'inhibiteurs de la pdk1 kinase
|
IN2014CN02646A
(fr)
|
2011-09-14 |
2015-08-07 |
Samumed Llc |
|
WO2013063321A1
(fr)
|
2011-10-25 |
2013-05-02 |
The General Hospital Corporation |
Inhibiteurs de la voie wnt/b-caténine et leurs procédés d'utilisation
|
PH12017500997A1
(en)
|
2012-04-04 |
2018-02-19 |
Samumed Llc |
Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
|
NZ724837A
(en)
|
2012-05-04 |
2018-05-25 |
Samumed Llc |
1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
|
WO2014041518A1
(fr)
*
|
2012-09-14 |
2014-03-20 |
Glenmark Pharmaceuticals S.A. |
Composés thiénopyrrole comme inhibiteurs de l'itk
|
MX370487B
(es)
|
2013-01-08 |
2019-12-16 |
Samumed Llc |
Inhibidores de 3-(benzo-imidazol-2-il)-indazol de la senda de señalización de wnt y usos terapéuticos de los mismos.
|
CN104370889A
(zh)
*
|
2013-01-24 |
2015-02-25 |
韩冰 |
一类降低眼压的化合物及其制备方法和用途
|
RS58432B1
(sr)
|
2013-02-22 |
2019-04-30 |
Samumed Llc |
Gama-diketoni kao aktivatori wnt/beta-kateninakog signalnog puta
|
WO2014137728A1
(fr)
|
2013-03-04 |
2014-09-12 |
Merck Sharp & Dohme Corp. |
Composés inhibant l'activité enzymatique de la kinase à répétition riche en leucine
|
WO2014134772A1
(fr)
*
|
2013-03-04 |
2014-09-12 |
Merck Sharp & Dohme Corp. |
Composés inhibant l'activité enzymatique de la kinase à séquence répétée riche en leucine
|
WO2014134774A1
(fr)
|
2013-03-04 |
2014-09-12 |
Merck Sharp & Dohme Corp. |
Composés inhibant l'activité enzymatique de la kinase à séquence répétée riche en leucine
|
WO2014134776A1
(fr)
|
2013-03-04 |
2014-09-12 |
Merck Sharp & Dohme Corp. |
Composés inhibant l'activité enzymatique de la kinase à séquence répétée riche en leucine
|
US20140275160A1
(en)
|
2013-03-15 |
2014-09-18 |
Aerie Pharmaceuticals, Inc. |
Combination therapy
|
WO2015015519A1
(fr)
|
2013-07-31 |
2015-02-05 |
Council Of Scientific & Industrial Research |
Nouveaux composés d'indazole et leur procede de preparation
|
JP6525983B2
(ja)
|
2013-10-18 |
2019-06-05 |
ユニバーシティー ヘルス ネットワーク |
膵癌の治療法
|
TWI675028B
(zh)
|
2014-07-24 |
2019-10-21 |
美商貝達醫藥公司 |
做為週期素依賴型激酶(cdk)抑制劑之2-h-吲唑衍生物及其醫療用途
|
LT3206686T
(lt)
|
2014-08-20 |
2020-01-10 |
Samumed, Llc |
Gama-diketonai, skirti senėjančios odos ir raukšlių gydymui ir profilaktikai
|
WO2016040188A1
(fr)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine et ses utilisations thérapeutiques
|
WO2016040181A1
(fr)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine et ses utilisations thérapeutiques
|
WO2016040185A1
(fr)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
2-1h-indazol-3-yl)-3h-imidazo[4,5-b]pyridine et ses utilisations thérapeutiques
|
WO2016040193A1
(fr)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine et ses utilisations thérapeutiques
|
WO2016040180A1
(fr)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[3,4-c]pyridine et ses utilisations thérapeutiques
|
WO2016040190A1
(fr)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine et ses utilisations thérapeutiques
|
WO2016040184A1
(fr)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine et ses utilisations thérapeutiques
|
WO2016040182A1
(fr)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
2-(1h-indazol-3-yl)-1h-imidazo[4,5-c]pyridine et ses utilisations thérapeutiques
|
GB201506660D0
(en)
|
2015-04-20 |
2015-06-03 |
Cellcentric Ltd |
Pharmaceutical compounds
|
GB201506658D0
(en)
|
2015-04-20 |
2015-06-03 |
Cellcentric Ltd |
Pharmaceutical compounds
|
GB201511382D0
(en)
|
2015-06-29 |
2015-08-12 |
Imp Innovations Ltd |
Novel compounds and their use in therapy
|
WO2017024015A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines et leurs utilisations thérapeutiques
|
WO2017023984A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines et leurs utilisations thérapeutiques
|
WO2017023993A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-indol-2-yl)-1h-pyrazolo[4,3-b]pyridines et leurs utilisations thérapeutiques
|
WO2017023987A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridines et leurs utilisations thérapeutiques
|
US10285982B2
(en)
|
2015-08-03 |
2019-05-14 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
US10463651B2
(en)
|
2015-08-03 |
2019-11-05 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1H-indazoles and therapeutic uses thereof
|
US10188634B2
(en)
|
2015-08-03 |
2019-01-29 |
Samumed, Llc |
3-(3H-imidazo[4,5-C]pyridin-2-yl)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
US10383861B2
(en)
|
2015-08-03 |
2019-08-20 |
Sammumed, LLC |
3-(1H-pyrrolo[2,3-C]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
US10519169B2
(en)
|
2015-08-03 |
2019-12-31 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-C]pyridin-2-yl)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
US10166218B2
(en)
|
2015-08-03 |
2019-01-01 |
Samumed, Llc |
3-(1H-indol-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
US10392383B2
(en)
|
2015-08-03 |
2019-08-27 |
Samumed, Llc |
3-(1H-benzo[d]imidazol-2-yl)-1H-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
US10195185B2
(en)
|
2015-08-03 |
2019-02-05 |
Samumed, Llc |
3-(1H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
WO2017024021A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-indazoles et leurs utilisations thérapeutiques
|
US10604512B2
(en)
|
2015-08-03 |
2020-03-31 |
Samumed, Llc |
3-(1H-indol-2-yl)-1H-indazoles and therapeutic uses thereof
|
WO2017024003A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines et leurs utilisations thérapeutiques
|
WO2017023996A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridines et leurs utilisations thérapeutiques
|
WO2017024004A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines et leurs utilisations thérapeutiques
|
US10519133B2
(en)
|
2015-08-07 |
2019-12-31 |
Medshine Discovery Inc. |
Vinyl compounds as FGFR and VEGFR inhibitors
|
WO2017079759A1
(fr)
|
2015-11-06 |
2017-05-11 |
Samumed, Llc |
2-(3h-indazol-3-yl)-1h-imidazo[4,5-c]pyridines et leurs utilisations anti-inflammatoires
|
AU2015414743B2
(en)
|
2015-11-17 |
2019-07-18 |
Alcon Inc. |
Process for the preparation of kinase inhibitors and intermediates thereof
|
US9643927B1
(en)
|
2015-11-17 |
2017-05-09 |
Aerie Pharmaceuticals, Inc. |
Process for the preparation of kinase inhibitors and intermediates thereof
|
AR108325A1
(es)
|
2016-04-27 |
2018-08-08 |
Samumed Llc |
Isoquinolin-3-il carboxamidas y preparación y uso de las mismas
|
AR108326A1
(es)
|
2016-04-27 |
2018-08-08 |
Samumed Llc |
Isoquinolin-3-il carboxamidas y preparación y uso de las mismas
|
HRP20221446T1
(hr)
|
2016-06-01 |
2023-01-06 |
Biosplice Therapeutics, Inc. |
Postupci za pripremu n-(5-(3-(7-(3-fluorofenil)-3h-imidazo[4,5-c]piridin-2-il)-1h-indazol-5-il)piridin-3-il)-3-metilbutanamida
|
CN107573332B
(zh)
*
|
2016-07-05 |
2022-04-19 |
广州再极医药科技有限公司 |
芳香乙炔或芳香乙烯类化合物、其中间体、制备方法、药物组合物及应用
|
US11352328B2
(en)
|
2016-07-12 |
2022-06-07 |
Arisan Therapeutics Inc. |
Heterocyclic compounds for the treatment of arenavirus
|
JP6907319B2
(ja)
|
2016-08-31 |
2021-07-21 |
アエリエ ファーマシューティカルズ インコーポレイテッド |
眼科用組成物
|
BR112019008061A2
(pt)
|
2016-10-21 |
2019-09-17 |
Samumed Llc |
métodos de uso de indazol-3-carboxamidas e seu uso como inibidores da via de sinalização de wnt/b-catenina
|
JP2019533702A
(ja)
|
2016-11-07 |
2019-11-21 |
サミュメッド リミテッド ライアビリティ カンパニー |
単回用量の調整済み注射用製剤
|
EP3609871A4
(fr)
|
2017-03-31 |
2021-01-06 |
Aerie Pharmaceuticals, Inc. |
Composés d'amide aryl cyclopropyl-amino-isoquinolinyl
|
US10604514B2
(en)
|
2017-10-19 |
2020-03-31 |
Samumed, Llc |
6-(5-membered heteroaryl)isoquinolin-3-yl carboxamides and preparation and use thereof
|
US10413537B2
(en)
|
2017-10-27 |
2019-09-17 |
Samumed, Llc |
6-(5-membered heteroaryl)isoquinolin-3-yl-(5-membered heteroaryl) carboxamides and preparation and use thereof
|
WO2019084497A1
(fr)
|
2017-10-27 |
2019-05-02 |
Samumed, Llc |
6-(hétéroaryle et aryle à 6 chaînons)isoquinolin-3-yl carboxamides, leur préparation et leur utilisation
|
WO2019089835A1
(fr)
|
2017-10-31 |
2019-05-09 |
Samumed, Llc |
Diazanaphthalèn-3-yl carboxamides, préparation et utilisation de ceux-ci
|
CN109988144B
(zh)
|
2017-12-29 |
2024-07-05 |
广州再极医药科技有限公司 |
芳香乙烯或芳香乙基类衍生物、其制备方法、中间体、药物组合物及应用
|
BR112020017087A2
(pt)
|
2018-02-23 |
2020-12-22 |
Samumed, Llc |
Indazol-3-carboxamidas substituídas 5-heteroarila e preparação e uso das mesmas
|
WO2019241540A1
(fr)
|
2018-06-15 |
2019-12-19 |
Samumed, Llc |
Macrocycles contenant de l'indazole et utilisations thérapeutiques associées
|
CA3112391A1
(fr)
|
2018-09-14 |
2020-03-19 |
Aerie Pharmaceuticals, Inc. |
Composes d'amide aryl cyclopropyl-amino-isoquinolinyl
|
WO2020150545A1
(fr)
|
2019-01-17 |
2020-07-23 |
Samumed, Llc |
DÉRIVÉS DE PYRAZOLE UTILISÉS COMME MODULATEURS DE LA VOIE DE SIGNALISATION WNT/β-CATÉNINE
|
CN114072387B
(zh)
*
|
2019-11-06 |
2024-03-08 |
暨南大学 |
吲唑类化合物及其药用组合物和应用
|
WO2021125229A1
(fr)
*
|
2019-12-17 |
2021-06-24 |
富士フイルム株式会社 |
Composé d'indazole ou sel de celui-ci, et composition pharmaceutique
|
WO2021121420A1
(fr)
*
|
2019-12-20 |
2021-06-24 |
江苏凯迪恩医药科技有限公司 |
Composé benzopyrazole et intermédiaire, procédé de préparation correspondant et utilisation associée
|
WO2021168341A1
(fr)
|
2020-02-21 |
2021-08-26 |
Samumed, Llc |
Formes solides de 1-(5-(3-(7-(3-fluorophényl)-3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridin-5-yl)pyridin-3-yl)-n,n-diméthylméthanamine
|
KR20230152654A
(ko)
|
2020-12-30 |
2023-11-03 |
타이라 바이오사이언시스, 인크. |
키나아제 억제제로서의 인다졸 화합물
|
CN112724134B
(zh)
*
|
2021-01-14 |
2022-04-01 |
复旦大学 |
氮杂吲唑联吡啶衍生物髓细胞增殖抑制剂及其制备方法与在制药中的应用
|
WO2023240138A1
(fr)
*
|
2022-06-08 |
2023-12-14 |
Blossomhill Therapeutics, Inc. |
Macrocycles contenant de l'indazole et leur utilisation
|